Figure 1 (Vyvgart 01)
Vyvgart Hytrulo Injection, Solution
Product Images NDC 73475-1221
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vyvgart Hytrulo (NDC 73475-1221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Argenx Us, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Vyvgart 02)
Improvements in Total MG-ADL and Total QMG were observed at Week 4. No worsening was reported. The results indicate a positive impact of the treatment on the evaluated parameters. The text also mentions the presence of a placebo, suggesting a comparison between treatment and control groups.*
Principal Display Panel (5.6 mL Vial Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
